Patents by Inventor Ana Lúcia ALMEIDA FERREIRA

Ana Lúcia ALMEIDA FERREIRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230106913
    Abstract: The present disclosure relates to 6-substituted quinoline-2-piperidine derivatives for use in the treatment and/or prevention of tuberculosis.
    Type: Application
    Filed: December 28, 2020
    Publication date: April 6, 2023
    Inventors: Augusto Eugénio PARDAL FILIPE, Carla Patrícia DA COSTA PEREIRA ROSA, Ana Vanessa CORDEIRO SIMÕES, João Carlos RAMOS DAMIL, João Pedro SILVA SERRA, Ana Lúcia ALMEIDA FERREIRA, Rita Isabel GOMES NEVES, Sara Alexandra MARQUES HOMEM E SOUSA DOS SANTOS
  • Patent number: 9809550
    Abstract: The invention provides quinolyl-hydrazones of Formula I, or pharmaceutically acceptable salts, esters, solvates, isomers and prodrugs thereof as well as pharmaceutical compositions containing these compounds for use in the prophylactic and/or therapeutic treatment of tuberculosis and related diseases, such as, diseases caused by nontuberculous mycobacteria and/or caused by Micobacterium leprae.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: November 7, 2017
    Assignee: TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A.
    Inventors: Ana Lucia Almeida Ferreira, Ana Sofia Lopes, Augusto Eugenio Pardal Filipe, Pedro Filipe Eufrasio Pedroso, Susana Marques De Almeida Pecorelli, Carlos Caixado
  • Patent number: 9593103
    Abstract: The invention provides pyridyl-hydfazones of Formula I, or pharmaceutically acceptable salts, esters, solvates, isprriers and prodrugs thereof as well as pharmaceutical compositions containing these compounds for use in the prophylactic and/or therapeutic treatment of tuberculosis and related diseases, such as, diseases caused by nontuberculous mycobacteria and/or caused by Micobacterium leprae.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: March 14, 2017
    Assignee: TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A.
    Inventors: Ana Lucia Almeida Ferreira, Ana Sofia Lopes, Augusto Eugenio Pardal Filipe, Carlos Caixado, Pedro Filipe Eufrasio Pedroso, Susana Marques De Almeida Pecorelli
  • Publication number: 20150299128
    Abstract: The invention provides quinolyl-hydrazones of Formula I, or pharmaceutically acceptable salts, esters, solvates, isomers and prodrugs thereof as well as pharmaceutical compositions containing these compounds for use in the prophylactic and/or therapeutic treatment of tuberculosis and related diseases, such as, diseases caused by nontuberculous mycobacteria and/or caused by Micobacterium leprae.
    Type: Application
    Filed: November 20, 2013
    Publication date: October 22, 2015
    Applicant: TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A.
    Inventors: Ana Lúcia ALMEIDA FERREIRA, Ana Sofia LOPES, Augusto Eugéno PARDAL FILIPE, Pedro Filipe EUFRASIO PEDROSO, Susana Marques DE ALMEIDA PECORELLI, Carlos CAIXADO
  • Publication number: 20150284374
    Abstract: The invention provides pyridyl-hydfazones of Formula I, or pharmaceutically acceptable salts, esters, solvates, isprriers and prodrugs thereof as well as pharmaceutical compositions containing these compounds for use in the prophylactic and/or therapeutic treatment of tuberculosis and related diseases, such as, diseases caused by nontuberculous mycobacteria and/or caused by Micobacterium leprae.
    Type: Application
    Filed: November 20, 2013
    Publication date: October 8, 2015
    Applicant: TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A.
    Inventors: Ana Lucia Almeida Ferreira, Ana Sofia Lopes, Augusto Eugenio Pardal Filipe, Carlos Caixado, Pedro Filipe Eufrasio Pedroso, Susana Marques De Almeida Pecorelli